ClinicalTrials HQ

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT

Active, not recruiting · NCT04217278 · Registry updated 2026-05-05
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCTHemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasmActive, not recruitingPhase 2 / Phase 32026-05-05NCT04217278

3 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Adienne SA1
Jazz Pharmaceuticals60
University of Birmingham75

14 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Addenbrooke's HospitalCambridgeUnited Kingdom26
Churchill HospitalOxfordUnited Kingdom17
Derriford HospitalPlymouthUnited Kingdom27
Freeman HospitalNewcastleUnited Kingdom14
Hammersmith HospitalLondonUnited Kingdom14
King's College HospitalLondonUnited Kingdom45
Leicester Royal InfirmaryLeicesterUnited Kingdom19
Manchester Royal InfirmaryManchesterUnited Kingdom10
Nottingham City HospitalNottinghamUnited Kingdom19
Queen Elizabeth HospitalBirminghamUnited Kingdom23
Queen Elizabeth Hospital GlasgowGlasgowUnited Kingdom1
St James' University HospitalLeedsUnited Kingdom2
University Hospital of WalesCardiffUnited Kingdom25
University Hospitals BristolBristolUnited Kingdom3